NCT00002381View on ClinicalTrials.gov

The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Nelfinavir mesylate

DRUG

Nevirapine

DRUG

Stavudine

Trial Locations (2)

94109

Saint Francis Mem Hosp / HIV Care Unit, San Francisco

02908

Roger Williams Med Ctr, Providence

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00002381 - The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine | Biotech Hunter | Biotech Hunter